Header Logo

Connection

ANDREW CIVITELLO to Middle Aged

Back to Details
This is a "connection" page, showing publications ANDREW CIVITELLO has written about Middle Aged.
ANDREW CIVITELLO
Connection Strength
0.389
Middle Aged
  1. Medium to long-term ventricular assist device support in adults with congenital heart disease. J Heart Lung Transplant. 2025 Feb; 44(2):278-281.
    View in: PubMed
    Score: 0.015
  2. Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia Ablation. JACC Clin Electrophysiol. 2024 Sep; 10(9):2049-2058.
    View in: PubMed
    Score: 0.015
  3. Sex Disparities in Left Ventricular Assist Device Implantation: Delayed Presentation and Worse Right Heart Failure. ASAIO J. 2024 06 01; 70(6):469-476.
    View in: PubMed
    Score: 0.014
  4. Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy. Tex Heart Inst J. 2023 08 22; 50(4).
    View in: PubMed
    Score: 0.014
  5. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs. 2021 Jun; 24(2):207-216.
    View in: PubMed
    Score: 0.012
  6. Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial. Circulation. 2021 04 27; 143(17):1673-1686.
    View in: PubMed
    Score: 0.012
  7. Survival on the Heart Transplant Waiting List. JAMA Cardiol. 2020 11 01; 5(11):1227-1235.
    View in: PubMed
    Score: 0.012
  8. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients. ASAIO J. 2020 05; 66(5):539-546.
    View in: PubMed
    Score: 0.011
  9. Gastrointestinal Bleeding After HeartMate II or HVAD Implantation: Incidence, Location, Etiology, and Effect on Survival. ASAIO J. 2020 03; 66(3):283-290.
    View in: PubMed
    Score: 0.011
  10. Outcomes of Repeat Left Ventricular Assist Device Exchange. ASAIO J. 2020 01; 66(1):64-68.
    View in: PubMed
    Score: 0.011
  11. Effect of cardiac arrest with aortic cross-clamping during left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2020 01 01; 30(1):47-53.
    View in: PubMed
    Score: 0.011
  12. Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device. Ann Thorac Surg. 2020 06; 109(6):e439-e440.
    View in: PubMed
    Score: 0.011
  13. Long-Term Continuous-Flow Left Ventricular Assist Device Support After Left Ventricular Outflow Tract Closure. ASAIO J. 2019 08; 65(6):558-564.
    View in: PubMed
    Score: 0.011
  14. Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection. J Card Surg. 2019 Feb; 34(2):82-91.
    View in: PubMed
    Score: 0.010
  15. Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support. Ann Thorac Surg. 2019 04; 107(4):1132-1138.
    View in: PubMed
    Score: 0.010
  16. A Multisite Randomized Controlled Trial of a Patient-Centered Ventricular Assist Device Decision Aid (VADDA Trial). J Card Fail. 2018 Oct; 24(10):661-671.
    View in: PubMed
    Score: 0.010
  17. Effect of Preoperative Atrial Fibrillation on Patients with Chronic Heart Failure Who Undergo Long-Term Continuous-Flow LVAD Implantation. ASAIO J. 2018 Sep-Oct; 64(5):594-600.
    View in: PubMed
    Score: 0.010
  18. Continuous-Flow Left Ventricular Assist Device Therapy in Adults with Transposition of the Great Vessels. Ann Thorac Cardiovasc Surg. 2021 Feb 20; 27(1):64-67.
    View in: PubMed
    Score: 0.010
  19. Predictive value of preoperative serum albumin levels on outcomes in patients undergoing LVAD implantation. J Card Surg. 2018 Aug; 33(8):469-478.
    View in: PubMed
    Score: 0.010
  20. HeartMate II implantation technique that spares the sternum and ascending aorta. J Artif Organs. 2018 Dec; 21(4):458-461.
    View in: PubMed
    Score: 0.010
  21. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs. 2018 Sep; 21(3):285-292.
    View in: PubMed
    Score: 0.010
  22. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2018 08; 106(2):513-519.
    View in: PubMed
    Score: 0.010
  23. Bridging to a Long-Term Ventricular Assist Device With Short-Term Mechanical Circulatory Support. Artif Organs. 2018 Jun; 42(6):589-596.
    View in: PubMed
    Score: 0.010
  24. Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices. J Artif Organs. 2018 Jun; 21(2):180-187.
    View in: PubMed
    Score: 0.010
  25. Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle. Ann Thorac Surg. 2018 03; 105(3):799-806.
    View in: PubMed
    Score: 0.010
  26. Incidence, Predictors, and Significance of?Ventricular Arrhythmias in Patients With?Continuous-Flow Left Ventricular Assist Devices: A 15-Year Institutional Experience. JACC Clin Electrophysiol. 2018 02; 4(2):257-264.
    View in: PubMed
    Score: 0.009
  27. Frequency and Consequences of Right-Sided Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation. Am J Cardiol. 2018 02 01; 121(3):336-342.
    View in: PubMed
    Score: 0.009
  28. Left ventricular outflow tract closure during LVAD implantation: 2 cases of patients supported for over 6?years. J Artif Organs. 2017 Dec; 20(4):350-353.
    View in: PubMed
    Score: 0.009
  29. Outcomes in patients with advanced heart failure and small body size undergoing continuous-flow left ventricular assist device implantation. J Artif Organs. 2018 Mar; 21(1):31-38.
    View in: PubMed
    Score: 0.009
  30. Preoperative Prealbumin Level as a Predictor of Outcomes in Patients Who Underwent Left Ventricular Assist Device Implantation. Am J Cardiol. 2017 Dec 01; 120(11):1998-2002.
    View in: PubMed
    Score: 0.009
  31. Perforation of a HeartMate II outflow graft. J Card Surg. 2017 Mar; 32(3):233-234.
    View in: PubMed
    Score: 0.009
  32. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol. 2017 Jan; 48(1):27-34.
    View in: PubMed
    Score: 0.009
  33. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2015 Jan; 149(1):267-75, 278.e1.
    View in: PubMed
    Score: 0.008
  34. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol. 2014 Feb; 27(1):1-11.
    View in: PubMed
    Score: 0.007
  35. Trauma in patients with continuous-flow left ventricular assist devices. Am J Cardiol. 2013 Nov 01; 112(9):1520-2.
    View in: PubMed
    Score: 0.007
  36. Bivalirudin for treatment of aortic valve thrombosis after left ventricular assist device implantation. ASAIO J. 2013 Jul-Aug; 59(4):448-9.
    View in: PubMed
    Score: 0.007
  37. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009 Feb; 2(2):91-6.
    View in: PubMed
    Score: 0.005
  38. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008 Jan; 27(1):106-11.
    View in: PubMed
    Score: 0.005
  39. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006; 33(2):111-5.
    View in: PubMed
    Score: 0.004
  40. Arrhythmogenic right ventricular dysplasia: initial presentation in a middle-aged woman. Tex Heart Inst J. 2006; 33(3):386-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.